IBKR vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

IBKR

49.0
AI Score
VS
CME Wins

CME

59.1
AI Score

Investment Advisor Scores

IBKR

49score
Recommendation
HOLD

CME

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IBKR CME Winner
Forward P/E 28.169 21.9298 CME
PEG Ratio 1.4786 4.7092 IBKR
Revenue Growth 26.3% 0.8% IBKR
Earnings Growth 35.3% 2.5% IBKR
Tradestie Score 49.0/100 59.1/100 CME
Profit Margin 16.5% 63.4% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IBKR 1M: -0.9% · 3M: -8.0% CME 1M: -5.3% · 3M: +12.1%

Current Technical Phase

IBKR

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.5%) with fading momentum, RSI 47

RSI (14): 46.6 · Price: $88.30

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.6 · Price: $263.14

Fundamentals Snapshot

Metric IBKR CME
Market Cap — —
Forward P/E 27.6 20.4
Trailing P/E 33.9 22.2
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.9% 1.0%
Operating Margin 0.8% 0.7%
EPS 2.53 11.93
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.